BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Fumaderm® initial/Fumaderm® (fumaric acid derivatives): Avoiding the risk of opportunistic infections by adhering to regular laboratory controls and observing further warnings

Active substance: fumaric acid derivatives

The company Biogen Idec GmbH points out that it is absolutely necessary when using the medicinal products Fumaderm® initial/Fumaderm® to observe the warnings given in the Summary of Product Characteristics with regard to regular monitoring of the blood count (including differential blood counts) and the resulting therapeutic consequences.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 679KB, File is accessible